z-logo
Premium
IL‐33 induces IL‐13 production by mouse mast cells independently of IgE‐FcεRI signals
Author(s) -
Ho Lien H.,
Ohno Tatsukuni,
Oboki Keisuke,
Kajiwara Naoki,
Suto Hajime,
Iikura Motoyasu,
Okayama Yoshimichi,
Akira Shizuo,
Saito Hirohisa,
Galli Stephen J.,
Nakae Susumu
Publication year - 2007
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.0407200
Subject(s) - degranulation , immunoglobulin e , mast cell , interleukin 33 , cytokine , biology , immunology , immune system , interleukin 5 , interleukin 4 , stem cell factor , interleukin , microbiology and biotechnology , receptor , antibody , haematopoiesis , biochemistry , stem cell
The IL‐1‐related molecules, IL‐1 and IL‐18, can promote Th2 cytokine production by IgE/antigen‐FcεRI‐stimulated mouse mast cells. Another IL‐1‐related molecule, IL‐33, was identified recently as a ligand for T1/ST2. Although mouse mast cells constitutively express ST2, the effects of IL‐33 on mast cell function are poorly understood. We found that IL‐33, but not IL‐1β or IL‐18, induced IL‐13 and IL‐6 production by mouse bone marrow‐derived, cultured mast cells (BMCMCs) independently of IgE. In BMCMCs incubated with the potently cytokinergic SPE‐7 IgE without specific antigen, IL‐33, IL‐1β, and IL‐18 each promoted IL‐13 and IL‐6 production, but the effects of IL‐33 were more potent than those of IL‐1β or IL‐18. IL‐33 promoted cytokine production via a MyD88‐dependent but Toll/IL‐1R domain‐containing adaptor‐inducing IFN‐β‐independent pathway. By contrast, IL‐33 neither induced nor enhanced mast cell degranulation. At 200 ng/ml, IL‐33 prolonged mast cell survival in the absence of IgE and impaired survival in the presence of SPE‐7 IgE, whereas at 100 ng/ml, IL‐33 had no effect on mast cell survival in the absence of IgE and reduced mast cell survival in the presence of IgE. These observations suggest potential roles for IL‐33 in mast cell‐ and Th2 cytokine‐associated immune responses and disorders.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here